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Anton N. Sidawy, MD, MPH, Washington, DCIt is with great honor that I stand before you today as
the President of the Society for Clinical Vascular Surgery,
the second largest vascular surgery society. The SCVS is very
special; although it is a national society with the advantage of
meeting members from all over the United States, it has the
feel of a regional society in that you get to know many of
the members and you look forward to seeing them from
one meeting to another. I am most grateful to the members
of the Executive Council, Program Committee, and ad-
ministrative staff of this Society, who worked tirelessly to
make this year’s symposium one of the most successful
meetings. To do so, we built on the accomplishments of the
past Presidents, a distinguished group of vascular surgeons.
I am proud and honored to become a member of their
exclusive club and call them friends.
Recently, I became very interested in the Pay for Per-
formance (P4P) initiative of the Centers for Medicare and
Medicaid Services (CMS); what is going on in Washington
regarding P4P not only is important to understand, but is
also very interesting to watch. The interaction among gov-
ernment agencies, health care consumers, patients’ advo-
cate organizations, insurance companies, and provider or-
ganizations is a microcosm of the workings of the
government.
By addressing this topic, I aim to heighten our special-
ty’s interest in P4P, hoping that our involvement will lead
to programs that are clinically pertinent as well as patient
centered. This address is divided into four segments: the
current reimbursement system, which encourages volume
inflation without regard to measuring quality; the P4P
efforts of governmental agencies and private organizations;
outcome measurements, probably the most important step
in the P4P process; and the current status of funding of this
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892initiative. At the end, I offer my concerns and recommen-
dations as the P4P process evolves and matures.
CURRENT REIMBURSEMENT SYSTEM
Last year, 2005, marked the 40th anniversary of the
Medicare and Medicaid law that President Lyndon John-
son signed on July 30, 1965. Currently, over 42 million
seniors and disabled persons take advantage of this na-
tional system for most of their health care needs. Al-
though CMS pay for physicians, hospitals, and other
medical services, it is physicians’ reimbursement issues
that I would like to discuss. The physician reimburse-
ment system, which was once based on what was known
as customary, prevailing, and reasonable charges, well
compensated procedure-oriented specialties such as sur-
gery. That system was felt to be inequitable and infla-
tionary. In 1992, Medicare instituted the resource-based
relative value scale (RBRVS), significantly changing the
way physicians are paid. The RBRVS, the brainchild of
William Hsiao, a professor of economics at Harvard
University, aimed to decrease payment for procedure-
oriented specialties and increase it for those specialties
considered to be “cognitive” in nature, leading to the
prediction at the time that this new system would in-
crease reimbursement for those specialties by over 50%.1
The RBRVS includes “relative values” for each Current
Procedural Terminology (CPT) code based on estimates
of the amount of physician work, practice cost, and
medical liability premium costs involved. Each of these
components is geographically adjusted and then multi-
plied by a conversion factor that translates the total unit
value for the CPT code into a dollar amount.
The value of the conversion factor is determined by
CMS on an annual basis by using a complex formula
defined by federal statute that reflects Medicare’s infla-
tion rate (known as the Medicare Economic Index, or
MEI) and an “adjustment factor” based on the Sustain-
able Growth Rate (SGR). The SGR was created by
Congress in 1999 to control Medicare spending on
physicians’ services. It sets expenditure targets that take
into account the number of fee-for-service Medicare
beneficiaries and the nation’s overall economic growth.
If total physician spending exceeds the spending target
set by SGR, a negative adjustment of up to 7% is
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dated each year. Conversely, if total spending is below
the SGR, a bonus of up to 3% may be applied to the MEI.
The problem with SGR is that it attempts at the same
time to set prices for individual services while controlling
total Medicare spending. These two goals can very sel-
dom be accomplished simultaneously because as the
number of Medicare beneficiaries increases and the ser-
vices provided to them get more complex and costly, the
total spending for Medicare part B expands. To control
this expansion in Medicare spending, reimbursement for
individual services, as reflected by the value of the con-
version factor, has to drop in order to meet SGR targets.
The Medicare Payment Advisory Commission (Med-
PAC) warned in its report to Congress (to the Subcom-
mittee on Health of the Committee on Ways and Means
of the House of Representatives) as early as 2002 that
this method used to determine the value of the conver-
sion factor is flawed, recommended that Congress repeal
SGR, and predicted 4 years of negative impact on the
value of the conversion factor if this system was not
repealed.2
MedPAC’s predictions were right on target; the
value of the conversion factor was supposed to decrease
on an annual basis for a total decrease of 8.7% from 2003
to 2005. Under pressure from physicians’ and surgeons’
groups, Congress reversed this trend every single year,
increasing the value of the conversion factor by 4.5% in
the same time period. Similarly, for 2006, the conversion
factor was supposed to decrease by 4.4%; again Congress
reversed it and froze the value at the 2005 level. In
addition, the Government Accounting Office (GAO)
projects that the conversion factor will continue its de-
cline on an average of 4% to 5% per year over the next 5
years if the SGR law is not repealed by Congress, a total
of 20% drop by 2010 (Fig 1). MedPAC and GAO
predictions were validated by the just-released Medicare
Trustees report of 2006, which projects that physician
payments will be cut 4.7% in 2007 and that payment
rates would have to be reduced by 4% to 5% each year
through at least 2015.3 If the increase in practice costs
and inflation are factored in, the problem is even more
amplified. MedPAC’s report noted that this projected
decrease in physician reimbursement would have a neg-
ative impact on Medicare beneficiaries’ access to health
care and recommended controlling total Medicare
spending, not only physician reimbursement. The Amer-
ican Medical Association (AMA) predicted that this pro-
jected decrease in physician reimbursement will have a
profound effect on Medicare beneficiaries. The results of
an AMA-conducted survey indicated that if Medicare
payments are cut by 5% beginning in 2007, 45% of
physicians plan either to decrease (29%) or to stop (16%)
the number of new Medicare patients they accept, 20%
may be forced to reduce the number of established
patients they treat, 42% plan to discontinue nursing
home visits, 37% of physicians whose practices serve a
rural area will discontinue these services, and 71% willmake one or more significant changes in the care of their
patients, including reducing time spent with Medicare
patients, referring complex cases, or discontinuing cer-
tain services.4 The results of this survey confirm the fears
of MedPAC regarding Medicare beneficiaries’ access to
quality health care. One of the solutions proposed by
GAO was to replace SGR with fee updates based on MEI;
it was estimated that if the change were to take place, fee
updates would be in the range of 2.1% to 2.4% from 2006
to 2014 instead of the projected drop.
Obviously, this system, which is intended to control
volume and cost, perversely creates incentives to increase
volume; if physician reimbursement continues to drop and
Congress does not interfere on an annual basis to reverse
the negative updates in the conversion factor, physicians
may respond by increasing volume to make up for the
decrease in their income. This prediction was also made by
MedPAC report of 2002:
“An expenditure target approach, such as the SGR, as-
sumes that increasing updates if overall volume is con-
trolled, and decreasing updates if overall volume is not
controlled, provides physicians a collective incentive to
control the volume of services. However, this assumption
is incorrect because people do not respond to collective
incentives but individual incentives . . .. If anything, in the
short run an individual physician has an incentive to
increase volume under such a system and the sum of those
individual incentives will result in an increase in volume
overall.2”
A system that encourages volume inflation is a flawed
system, and many, including the American College of Sur-
geons (ACS), called for repealing SGR. Congress has also
been concerned that this system encourages volume infla-
Fig 1. Government Accountability Office (GAO) assessment of
conversion factor value based on the Sustainable Growth Rate
(SGR) formula. Note that the 2003, 2004, and 2005 positive
updates were mandated by congressional law for those years in-
stead of the drops in the conversion factor for those years as
projected by SGR formula. [Adapted from a presentation entitled
“Sustainable Growth Rate (GSR) System for Updating Medicare
Physician Fee” by Bruce Steinwald from the GAO on January 14,
2005.] In addition, the projected4.4% update for 2006 based on
the SGR formula was instead set by Congress at 0%, freezing the
value of the conversion factor at the 2005 level.tion without rewarding quality.
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Under congressional pressure, CMS has been hard at
work to find ways to reward quality, placing enormous
efforts in the P4P concept, also called value-based pur-
chasing. CMS is even promoting its own P4P mottos:
“The right care for every patient every time” or “Pay-
ment is traditionally determined by what was done to a
patient; P4P will allow payment to be determined by
what is done for a patient.” P4P is not a new concept; in
its current form, P4P has been used by businesses to
improve quality and efficiency. Various P4P schemes
include offering bonuses in addition to regular salary or
withholding part of the salary and allowing the employee
to earn it back as a reward for increased efficiency,
quality, or productivity. Such reward should be of a
sufficient value in order to result in the intended change
in behavior, and its application should be simple enough
to be understood by the employee and to allow ease in
implementation and monitoring.5 However, P4P may
have unintended consequences; for example, if only ef-
ficiency is rewarded, quality may suffer. Similarly, in
nonmedical fields, good performance may equate with
improved profits, perhaps without emphasis on quality.
When P4P models are used in the medical and surgical
fields, however, most think of performance in terms of
improved quality as represented by improved outcomes.
I would like to state at the outset that very few
peer-reviewed publications can be found to support this
approach. A recently published article in JAMA that
examined data on three performance outcome measures
(cervical cancer screening, mammography, and hemo-
globin A1c testing) concluded: “Paying clinicians to
reach a common, fixed performance target may produce
little gain in quality for the money spent and will largely
reward those with higher performance at baseline.”
Those above the target threshold feel that what they
need to do is keep the status quo to get the performance
bonus. In addition, the authors speculated that the
performance bonus was too modest, at 5% annually, to
result in a significant behavior change.6 However, de-
spite the absence of appropriate research validating the
merits of P4P, the process is not slowing down.
Monitoring the results and outcomes of surgery is
not new to this specialty. Surgery has always monitored
its results, and its members have long submitted them-
selves to public critique by peers and colleagues in mor-
tality and morbidity conferences on a weekly or monthly
basis. As early as the 1900s, Ernest Codman vigorously
championed the idea of reporting results against the
opposition of the medical establishment in his State of
Massachusetts. In 1908 Codman stated: “Every hospital
should follow every patient it treats long enough to
determine whether or not the treatment had been suc-
cessful and then to inquire, if not, why not?” However,
Dr Codman’s efforts were appreciated and their benefits
were realized long after his death.7 The concept of
hospital standardization, Dr Codman proposed in theACS clinical congress of 1912, led to the formation of
the Joint Commission of Accreditation of Hospitals in
1952, which became the present-day Joint Commis-
sion of Accreditation of Healthcare Organizations
(JCAHO).8
Although surgery has long monitored its own results
primarily by using the mortality and morbidity format,
cumulative results and outcomes on a surgeon, hospital,
state, or national level have not been collected except for
those high-visibility key procedures such as cardiac sur-
gery. For over two decades now, there has been a con-
cern that the government has been spending an enor-
mous amount of money on the Medicare and Medicaid
programs without an appreciable return on quality.
However, what brought this issue to the forefront and
increased the awareness of the public to the issue of
quality and patient safety are two documents produced
by the Institute of Medicine that received enormous
levels of publicity. These two documents identified the
problem of in-hospital medical errors and attempted to
propose solutions for it. To Err is Human, which was
published in 2000, estimated that 98,000 patients die
annually in American hospitals not as a consequence of
their disease, but because of medical errors.9 This pub-
lication highlighted the importance of improving health
care delivery systems. It also called for patients’ involve-
ment in their own care as a protective mechanism to
detect and avoid such mistakes. One of the recommen-
dations made to improve patient safety was improving
data collection and analysis.
Published a year later, Crossing the Quality Chasm
recommended that “all health care organizations, profes-
sional groups, and private and public purchasers pursue six
major aims; specifically, “health care should be safe, effec-
tive, patient-centered, timely, efficient, and equitable.” To
do so, this document suggested performance expectations
for the American health care system aligning the incentives
of reimbursement and accountability with improvement of
quality targets.10 Frustrated by the seemingly slow progress
of the efforts to institute performance measurement, the
Institute of Medicine produced another landmark docu-
ment in January 2006 entitled Performance Measurement:
Accelerating Improvement.11 This report, which was pro-
duced by a committee at the Institute of Medicine at the
request of Congress, focuses on selecting measures to sup-
port quality-improvement efforts. It is the first report in
what is known as the Pathways to Quality Health Care series,
which will also include payment incentives and quality-
improvement initiatives. This committee recommended
that Congress establish a National Quality Coordination
Board funded by the Medicare Trust Fund to oversee the
development of performance measures and their imple-
mentation.12
Surgical Care Improvement Project. For over a de-
cade now,13 CMS has been promoting improved quality
and efficiency by contracting with Quality Improvement
Organizations to monitor and improve quality of health
care delivery to Medicare beneficiaries in various states.
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improved quality by partnering with Premier Inc, a
nationwide organization of not-for-profit hospitals. The
participation of Premier hospitals in this project was
voluntary. This demonstration program was launched on
March 13, 2003. Thirty-four quality measures in five
acute clinical areas were tested. These areas included
acute myocardial infarction, coronary artery bypass graft,
heart failure, community-acquired pneumonia, and hip
and knee replacement surgery. CMS aimed to reward
top-performing hospitals by increasing their payment for
Medicare beneficiaries. For the top decile hospitals, the
bonus will be 2% of the Diagnosis-Related Group–based
prospective payment for the patients in the measured
condition for all Medicare fee-for-service beneficiaries.
Hospitals in the second decile will be paid a bonus
incentive of 1% of the Diagnosis-Related Group–based
prospective payment amount. Over 100 Premier hospi-
tals participate in this demonstration project.13
Although surgery was not an early focus of CMS efforts
in the P4P area, through a steering committee formed by a
collaboration of 10 national organizations including the
Agency for Healthcare Research and Quality (AHRQ), the
ACS, CMS, and the Centers for Disease Control and
Prevention, the Surgical Care Improvement Project (SCIP)
was born. This project was developed as an extension of the
Surgical Infection Prevention program, which aimed to
reduce perioperative infection by timely and appropriate
use of antibiotic prophylaxis. SCIP is based on the premise
that a good number of the complications in over 40 million
operations performed annually in the United States can be
avoided by appropriate perioperative care. In fact, SCIP’s
general aim is to reduce surgical morbidity and mortality by
25% by the year 2010.14 To do so, SCIP’s specific goals are
to reduce the incidence of:
1. Surgical site infection.
2. Perioperative adverse cardiac events.
3. Venous thromboembolic events.
4. Postoperative respiratory complications.
To monitor the implementation of the above goals,
specific outcome measures were put in place. For example,
to monitor timely and appropriate antibiotic coverage, the
following measures were to be implemented:
1. Prophylactic antibiotic received within 1 hour prior to
surgical incision.
2. Appropriate prophylactic antibiotic selection for surgi-
cal patients.
3. Prophylactic antibiotics discontinued within 24 hours
after surgery end time (48 hours for cardiac patients).
Such outcome measures are to be monitored, and
institutions that are in compliance will be financially
rewarded. Various states’ Quality Improvement Organi-
zations contracted with CMS to recruit physicians and
hospitals to implement SCIP. Quality Improvement Or-
ganizations have also worked on developing data collec-
tion systems and test their usability, in addition to pro-viding administrative support in some instances.
However, implementation of a fully mature P4P model is
not immediate, and actual P4P will probably be imple-
mented in 4 to 5 years. Until full maturation of the
program, voluntary reporting, pay for reporting, and pay
for participation will be implemented. CMS hope that
the voluntary and rewarded efforts put in place for
reporting and participation would raise the awareness of
health care providers and improve the quality of services
delivered to Medicare beneficiaries even before the ac-
tual implementation of mature P4P programs years later.
Physician Voluntary Reporting Program. Holding
itself to the implementation timeline, CMS announced
on October 28, 2005, that it would put in place a
Physician Voluntary Reporting Program (PVRP) to start
at the beginning of 2006. In the notification it published
on November 2, 2005, CMS stated that the PVRP is being
rolled out as a part of its overall quality-improvement
efforts to “substantially improve the health and function of
our beneficiaries by preventing chronic disease complica-
tions, avoiding preventable hospitalizations, and improving
the quality of care delivered.” The notification went on to
state that “CMS is committed to the development of report-
ing and payment systems that will support and reward quality”
and that “the quality initiatives aim to . . . ultimately support
new payment systems that provide more financial resources to
provide better care, rather than simply paying based on the
volume of the service.”
In order for CMS to implement this program, it used
the already established administrative system for physicians’
claims. Medicare instituted a group of G-codes (G for
government). These codes are reported along with the CPT
codes used to describe the service provided. For example,
to report whether an AV dialysis access was performed by
using autogenous tissue or prosthetic material, two G-
codes were approved: G8081 if the access was autogenous
and G8082 if it was not. PVRP originally called for data
collection on 36 quality measures. However, the number of
measures was revised on December 27, 2005, to include 16
measures only (Table I). Three measures of interest to
vascular surgery were retained, including placement of au-
togenous AV dialysis access, antibiotic prophylaxis in sur-
gical patients, and thromboembolism prophylaxis in surgi-
cal patients. Each measure has a numerator (the number of
G-codes reported) and a denominator that is specifically
defined for each measure. CMS will calculate the percent-
age rate for each of the measures reported and feed the data
back to providers who volunteer to participate. It intends to
start in 2006. There has been an objection from the AMA
against the use of G-codes by CMS to collect and report
data since the CPT includes category II codes that are also
intended to report quality. Until now, there has been no
final decision on which reporting system to use; initially, a
combination of the two may be used. CMS consider report-
ing by G-codes to be an interim step until more robust
systems based on data mining from electronic health
records are in more widespread use. Indeed, CMS are in the
process of developing prototypes for nationwide health
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the country toward using personal electronic health
records. Recently, Mike Leavitt, Department of Health and
Human Services Secretary, announced that his department
would be awarding $18.6 million in contracts to four groups
or consortia of health care and health information technology
organizations to develop such prototypes implementing elec-
tronic health records that can follow up consumers through-
out their lives. Each group is a partnership between technol-
ogy developers and health care providers. The idea is that each
consortium develops a prototype network for secure informa-
tion sharing among different health care providers to include
physicians, hospitals, laboratories, and pharmacies. In addi-
tion, the Department of Health and Human Services is
prompting all four groups to work together to ensure that
information flows seamlessly among the four networks. Once
a system that connects all health care markets matures, CMS
and other insurers will have a health care data mining capabil-
ity that can easily monitor the performance of health care
providers throughout the United States.15
AMA/Physician Consortium for Performance Im-
provement. To develop clinically valid and evidence-based
quality measures, the AMA formed the Physician Consor-
tium for Performance Improvement. The Consortium, of
which the ACS and the Society for Vascular Surgery (SVS)
are two of about 70 member organizations, enlists the
expertise of physicians and experts on methodology. Its
stated mission is “to improve patient health and safety by:
identifying and developing evidence-based clinical perfor-
mance measures that enhance quality of patient care and
Table I. Revised Physician Voluntary Reporting
Program measures starter set, December 27, 2005
1. Aspirin at arrival for acute myocardial infarction
2. Beta blocker at time of arrival for acute myocardial infarction
3. Hemoglobin A1c control in patients with type I or II diabe-
tes mellitus
4. Low-density lipoprotein control in patients with type I or II
diabetes mellitus
5. High blood pressure control in patients with type I or II
diabetes mellitus
6. Angiotensin-converting enzyme inhibitor or angiotensin-
receptor blocker therapy for left ventricular systolic
dysfunction
7. Beta blocker therapy for patients with prior myocardial
infarction
8. Assessment of elderly patients for falls
9. Dialysis dose in end-stage renal disease patients
10. Hematocrit level in end-stage renal disease patients
11. Receipt of autogenous arteriovenous fistula in end-stage
renal disease patients requiring hemodialysis*
12. Antidepressant medication during the acute phase for
patients diagnosed with a new episode of major depression
13. Antibiotic prophylaxis in surgical patients*
14. Thromboembolism prophylaxis in surgical patients*
15. Use of internal mammary artery in coronary artery bypass
graft surgery
16. Preoperative -blocker for patients with isolated coronary
artery bypass graft
*Performance measures of interest to vascular surgeons.that foster accountability; promoting the implementationof effective and relevant clinical performance improvement
activities; and advancing the science of clinical performance
measurement and improvement.” CMS contracts with the
Consortium directly or through a third party. Once the
proposed performance measures are in place, they are ready
to be vetted and endorsed by the National Quality Forum.
The Forum, which was incorporated in 1999 in response to
the report of the President’s Advisory Commission on
Consumer Protection and Quality in Health Care Industry,
promotes valid, comparative data needed to improve health
care quality.16 The National Quality Forum is now the
organization whose stamp of approval is important to legit-
imize a performance measure.
Ambulatory Care Quality Alliance and Surgical
Quality Alliance. The Ambulatory Care Quality Alliance
(AQA) emerged as a key player in CMS’ efforts to enlist the
support of various organizations for its performance measures.
Many organizations belong to AQA: specialty societies,
health care purchasers, health care insurers, government
agencies, consumer groups, and other quality care experts.
AQA was convened in September of 2004 by four organi-
zations: the American Academy of Family Physicians, the
American College of Physicians, America’s Health Insur-
ance Plans, and the AHRQ. The mission of this organiza-
tion is to “Improve health care quality and patient safety
through a collaborative process in which key stakeholders
agree on a strategy for measuring performance at the phy-
sician level; collecting and aggregating data in the least
burdensome way; and reporting meaningful information to
consumers, physicians and other stakeholders to inform
choices and improve outcomes.” A broad range of health care
organizations, consumer groups, specialty societies, health
care purchasers, and stakeholders joined AQA (Table II).17
Initially, surgery was not well represented in AQA; however,
realizing the importance of the issue at hand, the ACS and
other surgical organizations, including the SVS, joined the
effort.
In its first and invitational meeting held in Washington,
DC, on September 8, 2005, over 125 individuals represent-
ing about 50 organizations attended the AQA meeting,
which was facilitated by Dr Carolyn Clancy, the director of
AHRQ. The opening remarks were delivered by Dr Mark
McClellan, CMS administrator. This high level representa-
tion from CMS and AHRQ, both government agencies
under the Department of Health and Human Services,
points to the importance this department places on the
work of AQA. Staying true to its mission, the work of the
AQA was assigned to three major workgroups; perfor-
mance measurement, data sharing and aggregation, and
reporting workgroups. As an indication of the wide repre-
sentation of the AQA, the reporting workgroup was co-
chaired by Randy Johnson, the Director of Human Re-
sources Strategic Initiatives of Motorola Corporation, and
Dr Nancy Nielson, the Speaker of the House of Delegates
of the AMA. This collaboration between a representative
from Motorola, a health care purchaser, and the AMA, a
health care provider organization, was the idea behind the
formation of the AQA.
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deliberations of the AQA, ACS went a step further and
formed the Surgical Quality Alliance, hoping to involve all
surgical specialties and anesthesia to deal with issues of
surgical quality and develop surgery-specific measures. In
its first meeting in Washington, DC, on December 5, 2005,
the group discussed surgical quality measures to finalize
their definitions and G-code assignments (Table III). The
Surgical Quality Alliance became a very active group; its
organizational mission and goals statement highlight its
role in bringing surgical specialties together in developing
and collating surgical quality measures, disseminating the
information on quality initiatives and programs at the fed-
eral and private levels, and coordinating the response of the
surgical community to such initiatives.
To simplify the current process of developing a per-
formance measure: CMS requests a measure directly or
through a third party, and the Consortium writes the
measure, which is then vetted and endorsed by the
National Quality Forum. The AQA gets consensus
buy-in from stakeholders, and then CMS uses the mea-
sure for P4P purposes (Fig 2).
Fistula First breakthrough initiative. In addition to
working on quality measures, CMS are also delving into
the development of comprehensive P4P programs. Ac-
tually, the model for such programs is one of interest to
vascular surgeons: increasing the percentage of autoge-
Table II. Stakeholders participating in Ambulatory Care
Quality Alliance (AQA) meeting and/or workgroup
discussions
Physicians, hospitals, and other health care professionals include
the American College of Physicians, the American Academy of
Family Physicians, the American Medical Association (AMA),
the AMA Physician Consortium for Performance
Improvement, the American Board of Internal Medicine, the
American Board of Medical Specialties, the American College
of Cardiology, the American Academy of Pediatrics, the
American Academy of Allergy, Asthma and Immunology, the
American Osteopathic Association, and the American Hospital
Association
Private sector employers, business coalitions, and consumers
include the American Association of Retired Persons, the
Consumer/Purchaser Disclosure Project, the Leapfrog Group,
the National Business Group on Health, the National Business
Coalition on Health, the Pacific Business Group on Health,
Motorola, UPS, BellSouth, Xerox, and Marriott
Public purchasers and other government agencies include CMS,
OPM, AHRQ, and the Department of Treasury
Health insurance plans include Aetna, Cigna, Health Net,
Health Partners, Humana, Independence BCBS, Pacificare,
United Health Group, Wellchoice, Wellpoint, America’s
Health Insurance Plans, and Blue Cross/Blue Shield
Association
Accrediting organizations include NCQA, Joint Commission of
Accreditation of Healthcare Organizations, and URAC
CMS, Centers for Medicare and Medicaid Services; AHRQ, Agency for
Healthcare Research and Quality; NCQA, National Committee for Quality
Assurance; URAC, Utilization Review Accreditation Commission.
Current as of May 2005.nous AV access procedures performed nationally. Autog-enous accesses have better patency and fewer complica-
tions; therefore, the higher the rate of autogenous
accesses placed, the better renal failure patients will fare
and the less the expense will be. Obviously, CMS are
interested in both outcomes. With CMS’s encourage-
ment, a wide range of organizations provided represen-
tatives to the Fistula First coalition. This performance
program outgrew from the Fistula First Initiative, which
was launched by CMS in early 2004 in response to the
high percentage of prosthetic AV accesses placed nation-
ally and to the variation of this rate in different regions of
the United States. The Northwest and New England
regions enjoy the highest rates of autogenous accesses,
whereas the mid-Atlantic area has been plagued with
high rates of prosthetic grafts. With CMS’s encourage-
ment, a wide range of organizations (Table IV) provided
representatives to the Fistula First coalition, including
representatives from nephrology and surgery, dialysis
nurses, dialysis units, hospitals, and corporations, to
name a few. The main function of this group was to put
together, for CMS consideration, a comprehensive pro-
gram using financial performance incentives to increase
the rate of autogenous access nationally. The stated goals
of the effort were to improve the quality of hemodialysis
access care by promoting a “safe, effective, patient-
centered, timely, efficient, and equitable care provided to
individuals with end-stage renal disease.” From the very
beginning, representatives of vascular surgery played an
active role in this group’s deliberations; our group sub-
mitted a proposal suggesting that the financial incentives
should be limited in a P4P model to the surgeon per-
forming the procedure and to the dialysis unit that
maintains the access, the incentives should be large
enough to make a difference, and the data should be
adjusted for patient-related factors once the entire pro-
gram is rolled out. A document was submitted by the
Fistula First Coalition to CMS that included some, but
not all, of the points suggested by the vascular surgery
group.
One important and positive byproduct of the Fistula
First program was the introduction of a G-code by CMS to
improve the use of autogenous venous tissue for access
placement. This code, G0365, is eligible for reimburse-
ment and is intended for duplex ultrasound mapping of the
extremity’s venous outflow and arterial inflow.
Carotid stenting reimbursement. In its memoran-
dum on carotid stenting, CMS introduced perhaps the first
P4P program for a surgical specialty. CMS not only re-
quired specific conditions for facility certification, but they
also set the exact preoperative conditions and the anatomic
degree of disease that have to be met to satisfy their
conditions for reimbursement.
To maintain credentialing, CMS mandated that either
the facility or a contractor to the facility collect, analyze,
and submit to CMS, on a 6-monthly basis, data on all
carotid artery stenting procedures performed at the facility.
The data must be made available upon CMS request; a
facility continues be reimbursed for this procedure if it
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other words, P4P.
MEASURING OUTCOMES
Perhaps the most important steps in any P4P pro-
gram are data collection, aggregation, adjustment, anal-
ysis, and reporting. Interestingly enough, however, these
are the components that have not been well developed
yet. Data collection is primitive, relying on voluntary
programs and G-codes. Data aggregation is very limited
in its scope. Except for very few examples, data registries
that can be used on the national level are almost nonex-
istent. Available registries are not uniform, and each
collects different data points. Programs that use risk
adjustment are not available except for the VA and, now,
the ACS National Surgical Quality Improvement Pro-
gram (NSQIP) and the Society for Thoracic Surgery’s
Cardiac Surgery Program.
National Surgical Quality Improvement Program.
Table III. Surgical quality measures developed by the Sur
Measure: prophylactic antibiotics ordered
Numerator: number of patients with an individual or standing o
incision (or start time when no incision is made)
Denominator: all patients for whom antibiotic prophylaxis is ind
Denominator exclusion: documented medical reason
Measure: prophylactic antibiotics administered
Numerator: number of patients for whom prophylactic antibiot
no incision is made)
Denominator: all patients for whom antibiotic prophylaxis is or
Denominator exclusion: documented medical reason
Measure: prophylactic antiseptics administered
Numerator: number of patients for whom prophylactic antisept
Denominator: all patients for whom prophylactic antiseptics are
Denominator exclusion: documented medical reason
Measure: venous thromboembolism (VTE) prophylaxis ordered
Numerator: number of patients for whom appropriate VTE pro
Denominator: all patients for whom VTE prophylaxis is indicat
Denominator exclusion: documented medical reason
Measure: cardiac risk, history, current symptoms, and physical exa
Numerator: number of patients who were assessed for history o
current signs of cardiac risk
Denominator: all patients undergoing a procedure with a 10- o
Denominator exclusion: documented medical reason
Measure: preoperative smoking cessation
Numerator: number of patients who received information on th
Denominator: all patients undergoing a procedure with a 10- o
Denominator exclusions: nonsmokers, documented medical rea
Measure: surgical time-out
Numerator: number of patients for whom a surgical time-out w
and surgical site
Denominator: all patients undergoing a procedure with a 10- o
Denominator exclusion: none
Measure: patient copy of preoperative instructions
Numerator: number of patients who were given a copy of appro
Denominator: all patients undergoing a procedure with a 10- o
Denominator exclusion: documented medical reason (emergen
Measure: patient copy of postoperative instructions
Numerator: number of patients who were given a copy of posto
medications, proper incision care, symptoms of surgical site in
Denominator: all patients undergoing a procedure with a 10- o
Denominator exclusion: patient died before dischargeThere is no question that, for many years, the VA hasbeen on the forefront in establishing the premier na-
tional quality-improvement program in the nation. This
program was initiated in response to a 1986 congres-
sional law that mandated the VA to report its surgical
results annually comparing risk-adjusted outcomes with
the national average. Interestingly, Congress overlooked
the fact at the time that there were no risk-adjusted
national outcomes to compare to. This has not changed,
and NSQIP remains the first and only noncardiac, na-
tional, risk-adjusted, validated, peer-controlled, and out-
come-based system; it has been in existence for over 15
years.
NSQIP has proven to enhance positively the quality
of care of surgical patients in the VA system. From the
inception of this program in 1991 to 2002, the 30-day
incidence of mortality decreased by 27% and morbidity
by 45% in participating VA medical centers.18 Data on
every surgical procedure in VA Medical Centers per-
formed under general, epidural, or spinal anesthesia are
Quality Alliance
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re administered within 1 h before incision (or start time when
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r 90-collected; in addition, data on specific operations are
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carotid endarterectomy (CEA) performed under local or
regional anesthesia. Fifty-two preoperative variables (10
demographic, 30 clinical, and 12 laboratory variables),
15 clinical intraoperative variables, and thirty-three 30-
day outcome variables (to include 30-day mortality and
hospital length of stay) are collected by a nurse clinical
reviewer from electronic medical records on about
115,000 of the total procedures performed in 128 VA
hospitals annually. The data are adjusted on the basis of
Fig 2. A simplified representation of the current proces
Medicare and Medicaid Services; AMA, American M
Ambulatory Care Quality Alliance.
Table IV. Fistula First initiative participating
organizations (list not inclusive)
American Association of Kidney Patients
American Kidney Fund
American Nephrology Nurses Association
American Society of Nephrology
American Society of Pediatric Nephrology
Centers of Disease Control and Prevention
Centers for Medicare and Medicaid Services
Department of Veterans Affairs
DaVita
Forum of ESRD Networks
Society for Vascular Surgery
Louisiana Health Care Review
National Kidney Foundation
NIDDK
NJ Department of Health and Senior Services
Renal Physicians Association
Society of Interventional Radiology
US Renal Data System Coordinating Center
National Institute of Diabetes and Digestive and Kidney Diseases
National Renal Administrators Association
National Association of Nephrology Technicians
ESRD, End-stage renal disease; NIDDK, National Institute of Diabetes and
Digestive and Kidney Diseases.the preoperative risk factors transmitted to the DataCoordinating Center. The rationale for data adjustment
and analysis is based on a conceptual framework in which
outcomes of health care are determined by three factors:
namely, quality of care, patient risk factors, and random
variation. If patient’s risk factors are accounted for by
risk adjustment and random variation is accounted for by
statistical analysis, then outcome accounts for quality of
care. The risk-adjusted mortality and morbidity for the
particular group of patients are reported as expected.
The ratios of observed over expected mortality and mor-
bidity (O/E ratio) are reported to chiefs of surgery on a
quarterly basis through a brief report. Annually, a volu-
minous report is sent to the Chief of Surgery and the
leadership of each medical center; it includes data collec-
tion, analysis, and, most importantly, comparison with
other VA medical centers around the country. The prac-
tices of low-outlier medical centers with O/E ratio sig-
nificantly below 1.0 are considered best practices and are
fed back to other medical centers for their consideration
and implementation. The validation study has shown
that high outliers have inferior structures and processes
of care when compared with low outliers.18-20 The NS-
QIP Executive Committee reviews on an annual basis the
preceding 4 years’ cumulative results; those medical
centers that are consistently high outliers are asked to
review specific areas of concern or are visited by a team
that would analyze their programs and offer suggestions
for change.
NSQIP’s leadership is considering future directions for
the program, which may include collecting data on long-
term survival, functional outcomes, quality of life, patients’
satisfaction, and cost-effectiveness, to name a few. In addi-
tion, it is considering the development of process measures
the development of quality measures. CMS, Centers for
l Association; NQF, National Quality Forum; AQA,s for
edicathat directly affect outcome.18
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on veterans’ health care, private institutions expressed in-
terest in extending this database to nonfederal hospitals.
This prompted a pilot study in 1999 to alpha test the
program in three non-VA hospitals (University of Michi-
gan, Emory University, and University of Nebraska). When
the applicability of this program was proven in this pilot
study, the ACS, through a grant from AHRQ, extended
this program to 11 additional hospitals in a beta test study.
This program, ACS-NSQIP, has been implemented in over
100 hospitals nationwide. In addition, procedure-specific
modules based on the NSQIP database, such as bariatric
surgery, are being developed by the College in collabora-
tion with specialty societies. Already, NSQIP is serving as a
P4P platform for private sector initiatives. Blue Cross/Blue
Shield of Michigan started in November of 2005 paying 15
hospitals to participate in ACS-NSQIP and contributing
data on general and vascular procedures. This project was
an extension of another one that started in 1997 in which
Blue Cross/Blue Shield of Michigan paid part of the cost to
Michigan hospitals for providing data on percutaneous
coronary interventions. During this pay for participation
program, no site- or provider-specific data were revealed to
Blue Cross/Blue Shield of Michigan or the general public;
the data were used by institutions to create quality-im-
provement measures. This project resulted in a significant
drop in complications and a 27% drop in mortality from
coronary interventions.21 ACS-NSQIP seems to be the
most logical platform to be used for CMS’ SCIP program.
Actually, CMS and its director, Dr McLellan, are very
interested in NSQIP migration to the private sector. It is
estimated that NSQIP will become the platform for CMS
P4P initiatives.22
SVS carotid stenting and endarterectomy registry.
In direct response to CMS’ reimbursement policy for
carotid stenting, which required hospitals to maintain
ongoing data and information about these procedures,
the Outcomes Committee of the SVS headed by immedi-
ate past President Greg Sicard and supported by current
President Enrico Ascher and the leadership of the SVS,
urgently put together the SVS carotid stenting and CEA
registry. This database is designed to comply with CMS
payment requirements and collect long-term data on ca-
rotid stenting and CEA. Currently, this is the only registry
that incorporates CEA data in addition to stenting. The
registry is Health Insurance Portability and Accountability
Act compliant and Web based and provides the ability of
designated individuals in each of the participating medical
centers to obtain real-time reports of their center’s results
with comparison to national averages and other centers in a
blinded fashion. Institutions that participate in this data-
base are ready to provide CMS with the data required for
their recredentialing.23
FUNDING
Perhaps there is no other issue that engenders more
heated and passionate discussion than the issue of fund-ing. Appropriate and widespread implementation of P4P
will require a considerable infrastructure, the expense of
which will be borne by hospitals for inpatients and by
physicians for patients in their practice. Although P4P
has implicit incentives due to improved efficiency, de-
creased morbidity, and improved outcomes, direct in-
centive payment for P4P is what counts to providers. The
sources for such direct incentives can be additional fund-
ing over and above established reimbursement; this is the
method preferred by providers and the one that makes
most sense. Less favorable methods include withholding
a certain percentage of reimbursement to be earned back
when certain performance measures are met or a method
that has been recently discussed, which is to increase
funding for the top performers and reduce it for the
bottom performers compared with norms.24 In the
minds of many, the last two options amount to yet
another decrease in reimbursement that would be over
and above the expected drop in the value of the conver-
sion factor of 4% to 5% a year over the next five or more
years.
Although all discussions indicate to the use of addi-
tional funding for P4P, such funding has yet to be
allocated by Congress. A bill sponsored by Representa-
tive Nancy Johnson that proposed funding for P4P
programs in the 2006 budget was encouraging; however,
hopes were dashed when the budget reconciliation bill
that finally passed included a widely reported $36 billion
in Medicare cuts over the next 5 years with no funding
for P4P. I would like to point out that the lack of
appropriated funds is definitely not slowing down this
process; it is going on as strong as ever. Actually, CMS
rolled out the PVRP program with no additional funding
or financial incentives provided. Also, on February 21,
2006, an article in the New York Times shed light on a
“joint House-Senate working agreement with the AMA”
signed on December 16, 2005, by Dr Duane Cady,
Chairman of the AMA Board, and by Chairmen Grassley,
Thomas, and Deal on behalf of Congress. In this “con-
fidential” agreement, AMA committed to developing
about 140 physician performance measures in 34 clinical
areas by the end of 2006. The agreement also included a
commitment that doctors will voluntarily report to the
federal government data on these quality measures by
2007. In a letter to the AMA, the presidents of seven
medical specialty groups objected that AMA signed this
agreement without consultation with their groups, partly
basing their objection on the fact that the AMA did not
get assurances that physicians will be adequately com-
pensated for participating in this P4P initiative. In re-
sponse to the Times article, Michael Maves, the Execu-
tive Vice President of the AMA, sent a memo to national
medical specialty societies and state medical associations
clarifying the agreement. In his memo, Maves stated that
the Congressional leaders were committed to address
payment and quality reforms in 2006. Dr Maves also
maintained that the AMA was under intense pressure to
agree to the points stated in the memo, indicating that
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As P4P systems are being devised, we need to recog-
nize issues of concern that need to be addressed. These
include the lack of testing and validation of performance
measures and the paucity of level 1 or even level 2
evidence on which to base performance measures for the
majority of surgical and vascular procedures. In addition,
attention should be paid to developing process measure-
ments that assess the complete surgical experience and
continuum of care and not only short-term outcomes.
This would include indications, preoperative evaluation,
operative parameters, and long-term outcomes. Recent
discussions have revolved around “efficiency measures”;
although, during discussions about the “efficiency of
care” the cost of care is always linked to quality to
produce efficiency measures, it is of concern that the cost
of providing care becomes a goal in and of itself. Fur-
thermore, CMS and various private healthcare purchas-
ers and insurance companies are pushing hard for expe-
diency in the development of P4P measures and
initiatives; it is concerning that the process is moving
ahead of the infrastructure needed to support it. In
addition, many other questions remain: How should we
set performance targets? How many data should be
required, and who should collect them? How about risk
adjustment, and should we accept non–risk-adjusted
data as a basis for P4P? Should providers be rewarded if
they meet a target or if they improve from their baseline?
Should incentives be directed to physicians, hospitals, or
a combination of those?
As this process is rapidly moving forward, Vascular
Surgery can take the position that the actual implemen-
tation of a comprehensive program is few years away, pay
no attention to it now, and play catch up later or,
preferably, be involved in the process. As we examine our
options, please consider the following: It is incumbent
upon us, as surgeons and vascular surgeons, to be fully
engaged in all aspects of this process, populating various
national and local committees, subcommittees, and
workgroups to maximize our impact. To do so, we need
volunteers who are willing to dedicate their time and
effort to this process. We need especially the involvement
of those in private practice. These colleagues are going to
deal with these issues in their offices and practices; their
challenges can be very different from those in full-time
practice. Their input will be highly valuable.
Our influence will help make P4P medically and surgi-
cally pertinent and, thus, more acceptable. We should
encourage our institutions to participate in ACS-NSQIP.
The process is ongoing, and the sooner we get involved in
it, the better. Vascular surgeons have always submittedthemselves to self-critique. We have never shied away from
discussing our complications; we should not be apprehen-
sive or worried now about numerically representing our
overall performance.
Finally, P4P is here to stay. The tide is too strong to
reverse. No type of practice will be immune since both
the public and private sectors are highly interested in
seeing P4P programs expand and mature; they see it as an
opportunity to improve quality and curtail cost. Most
importantly, P4P has the full support of consumer
groups, the most prominent of which is the American
Association of Retired Persons (AARP). This common
interest in this one issue by Congress, insurance compa-
nies, health care purchasers, and the AARP is very pow-
erful. The last time these groups got together, the un-
imaginable happened; Congress enacted the Medicare
Drug Prescription Bill!
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